Geode Capital Management LLC lifted its position in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 1.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,859,132 shares of the company's stock after acquiring an additional 109,273 shares during the quarter. Geode Capital Management LLC owned 2.43% of Cardinal Health worth $691,145,000 at the end of the most recent reporting period.
A number of other large investors also recently bought and sold shares of CAH. Norges Bank purchased a new stake in shares of Cardinal Health in the 4th quarter worth approximately $246,748,000. State Street Corp boosted its stake in Cardinal Health by 4.6% in the 3rd quarter. State Street Corp now owns 14,177,641 shares of the company's stock worth $1,566,913,000 after purchasing an additional 627,253 shares in the last quarter. Raymond James Financial Inc. purchased a new position in Cardinal Health in the 4th quarter worth $45,115,000. Two Sigma Advisers LP boosted its position in Cardinal Health by 47.9% in the third quarter. Two Sigma Advisers LP now owns 1,069,462 shares of the company's stock valued at $118,197,000 after buying an additional 346,362 shares during the last quarter. Finally, Worldquant Millennium Advisors LLC lifted its position in Cardinal Health by 77.3% during the third quarter. Worldquant Millennium Advisors LLC now owns 593,007 shares of the company's stock valued at $65,539,000 after purchasing an additional 258,541 shares during the period. Hedge funds and other institutional investors own 87.17% of the company's stock.
Cardinal Health Price Performance
CAH traded up $5.75 during trading hours on Wednesday, hitting $130.75. 4,287,129 shares of the stock were exchanged, compared to its average volume of 2,167,872. The stock has a market cap of $31.59 billion, a price-to-earnings ratio of 24.39, a price-to-earnings-growth ratio of 1.49 and a beta of 0.61. The stock has a 50-day simple moving average of $129.13 and a 200-day simple moving average of $122.10. Cardinal Health, Inc. has a 12 month low of $93.17 and a 12 month high of $139.50.
Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. Sell-side analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.
Cardinal Health Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be paid a $0.5056 dividend. The ex-dividend date is Tuesday, April 1st. This represents a $2.02 annualized dividend and a dividend yield of 1.55%. Cardinal Health's payout ratio is currently 37.69%.
Wall Street Analysts Forecast Growth
Several brokerages recently commented on CAH. Citigroup boosted their price target on shares of Cardinal Health from $120.00 to $129.00 and gave the stock a "neutral" rating in a report on Friday, January 10th. Wells Fargo & Company upped their price objective on Cardinal Health from $135.00 to $136.00 and gave the company an "equal weight" rating in a research note on Tuesday, February 4th. TD Cowen raised shares of Cardinal Health from a "hold" rating to a "buy" rating and boosted their price objective for the stock from $130.00 to $144.00 in a report on Wednesday, January 8th. Argus set a $148.00 price objective on shares of Cardinal Health in a research report on Tuesday, February 4th. Finally, Jefferies Financial Group upgraded Cardinal Health from a "hold" rating to a "buy" rating and increased their price target for the company from $140.00 to $150.00 in a report on Wednesday, February 5th. Four analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $140.14.
Check Out Our Latest Analysis on Cardinal Health
About Cardinal Health
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
See Also

Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.